ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Novel biomimetic mesoporous silica nanoparticle system possessing targetability and immune synergy facilitates effective solid tumor immuno-chemotherapy

Zhu, Haoran; Liu, Yang; Yi, Xinfeng; Zhu, Chuyun; Fu, Yuanyue; Huang, Zerong; Zhu, Kairui; Zhang, Wencai; Hou, Huige; Sun, Chenghong; Zhong, Cheng; Liu, Wei*; Li, Zhizhong*; Wang, Baocheng*; Wo, Jin*清华大学; 1; 5
BIOMATERIALS ADVANCES2023-1DOI: 10.1016/j.bioadv.2022.213229
5被引4阅读
引用收藏
分享

摘要

New strategies that enhance both the targetability of chemotherapy drugs and the synergistic effects of chemotherapy and immunotherapy are urgently needed for efficacious solid tumor therapy. In this study, a novel biomimetic nanoparticle system possessing the properties of tumor targeting and immune synergy was designed to meet these requirements. Mesoporous silica nanoparticles loaded with the chemotherapeutic drug doxorubicin (DOX) were coated with cell membranes modified by glycosylphosphatidylinositol (GPI)-anchored anti-HER2 single chain variable fragment (scFv) and the GPI-anchored co-stimulatory molecule CD80 (to promote solid tumor-targeted chemotherapy and cooperated immunotherapy, respectively). The impact of the nanotherapeutic system on both tumor-targeted chemotherapy and cellular immune response was investigated through in vitro and in vivo experiments. The results show that the novel biomimetic therapeutic system effectively promoted antitumor efficiency in vitro and in vivo. In addition, this therapeutic system further enhanced antitumor capacity by increasing CD8+ T cell activation and cytokine production and reducing myeloid-derived suppressor cell (MDSC) levels in tumors.

学科与关键词

关键词
Breast tumorTumor targetabilityImmunoregulationMesoporous silicaCD80Immunotherapy
相关
加载中…
  • Leveraging efferocytosis blockade for improved cancer chemo-immunotherapy through synchronized release of doxorubicin and BMS777607 confined within tailored mesoporous silica nanoparticles
    Zhang, Jing-Yang; Chen, Fang-Man; Li, Yu-Xuan; Duan, Qi-Jia; Wu, Chong; Zheng, Sui-Juan; Leong, Kam W.; Shao, Dan*; Du, Jin-Zhi*Nano Today, 2023, 53: 102039.
  • Study on biomimetic nano tumor targeted delivery system for chemotherapy-laser immunotherapy
    Liu, Yang*; Wang, Tong; Ren, Yachao; Li, Shuli; Fu, Jijun*; Shi, Jun*European Journal of Pharmaceutics and Biopharmaceutics, 2022, 176: 133-152.被引 2
  • Biomimetic Diselenide-Bridged Mesoporous Organosilica Nanoparticles as an X-ray-Responsive Biodegradable Carrier for Chemo-Immunotherapy
    Shao, Dan*; Zhang, Fan; Chen, Fangman; Zheng, Xiao; Hu, Hanze; Yang, Chao; Tu, Zhaoxu; Wang, Zheng; Chang, Zhimin; Lu, Junna; Li, Tianyu; Zhang, Yuan; Chen, Li; Leong, Kam W.*; Dong, Wen-fei*Advanced Materials, 2020, 32(50): 2004385.被引 142
查看全部 →

发表信息

论文状态
公开发表
期刊
BIOMATERIALS ADVANCES
发表日期
2023-01
卷期
第 144 卷
页码
213229
DOI
10.1016/j.bioadv.2022.213229
成果收录
SCIE
资助标注
Fundamental and Applied Basic Research Fund of Guangdong [2021A1515111217]; Medical Scientific Research Foundation of Guangdong Province of China [A2019217]

作者

  • Z

    Zhu, Haoran (第一作者)

    1 · 5

  • L

    Liu, Yang

    1 · 5

查看全部 15 位作者收起作者
  • Y

    Yi, Xinfeng

    zhuhai peoples hosp

  • Z

    Zhu, Chuyun

  • F

    Fu, Yuanyue

    1 · 5

  • H

    Huang, Zerong

    1 · 5

  • Z

    Zhu, Kairui

    1 · 5

  • Z

    Zhang, Wencai

    1 · 5

  • H

    Hou, Huige

    1 · 5

  • S

    Sun, Chenghong

  • Z

    Zhong, Cheng

  • L

    Liu, Wei (通讯)

  • L

    Li, Zhizhong (通讯)

    1 · 5

  • W

    Wang, Baocheng (通讯)

    tsinghua univ

  • W

    Wo, Jin (通讯)

    1 · 5

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417